期刊文献+

表阿霉素和紫杉醇单用或联合使用对乳腺肿瘤细胞ZR75-1的体外细胞毒性 被引量:4

Cytotoxicity of Epirubicin and Paclitaxel Alone or in Combination with Breast Tumor Cell ZR75-1 in Vitro
下载PDF
导出
摘要 目的观察表阿霉素联合紫杉醇方案对乳腺肿瘤细胞的增殖抑制作用。方法采用结晶紫染色法,比较表阿霉素及紫杉醇单用及联合应用对乳腺癌细胞ZR75-1的增殖抑制率。结果 1 mg·ml-1表阿霉素和3 mg·ml-1紫杉醇联合作用40 h,其联合效应Q值为0.935。结论 1 mg·ml-1表阿霉素和3 mg·ml-1紫杉醇联合应用40 h对ZR75-1细胞的增殖抑制具有相加作用。 Objective To observe the inhibitory effect of paclitaxel plus epirubicin on breast cancer cells proliferation.Methods The inhibitory effect of epirubicin and paclitaxel alone or in combined use on breast cancer(ZR75-1)cells were evaluated by crystal violet staining method.Results The combined effect factor Q was 0.935 after 40 h of combined use of epirubicin and paclitaxel at high concentrtation levels.Conclusion The inhibitory action for ZR75-1 cell is enhanced by combined use of 1 mg · ml-1 epirubicin and 3 mg · ml-1 paclitaxel at 40 h.
出处 《解放军药学学报》 CAS 2012年第4期342-344,共3页 Pharmaceutical Journal of Chinese People's Liberation Army
基金 国家自然科学基金 No.30901870
关键词 表阿霉素 紫杉醇 ZR75-1 细胞毒性 proliferation epirubicin paclitaxel ZR75-1 cytotoxicity
  • 相关文献

参考文献4

二级参考文献29

  • 1刘芳,江泽飞,宋三泰,刘晓晴,王涛,闫敏,张少华,郝春芳,孙君重,申戈.单药紫杉醇治疗晚期乳腺癌剂量强度与疗效和毒性的关系[J].中华肿瘤杂志,2005,27(1):56-58. 被引量:36
  • 2孙燕,张湘茹,张弘纲,张和平,孙国光.以表阿霉素为主的化疗方案治疗晚期恶性肿瘤516例[J].中华内科杂志,1997,36(3):183-186. 被引量:21
  • 3Shimizu T. Weekly administration of paelitaxel and pirambieine for recurrent breast cancer[J].Can To Kagaku Ryoho,2003,30 (1) : 105 - 109.
  • 4Sledge GW,Neuberg D,Belmardo P,et al. Phase III trial or doxombicin, paelitaxel,and the combination on doxorubiein and paelitaxel as frontline chemotherapy for metastatic breast cancer: an intergroup trial ( E 1193) [J]. J CAin Onc01,2003,21 (4) :588 - 592.
  • 5Conte PF, Baldini E, Gennari A, et al. Dose-finding study and pharmacokinetics of epirubicin and paclitaxel over 3 hour: a regimen with high activity and low cardiotoxicity in advanced breast cancer[J]. J Clin Oncol, 1997,15 (7) :2510 - 2517.
  • 6Horwitz SB, Cohen D, Rao S, et al. Taxel: Mechanisms of action and resistance [ J ]. J Nail Cancer Inst, 1993,15 : 15 - 61.
  • 7Sudat, Takahashi T, Golstein P, et al. Moleculor Cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family [ J ]. cell, 1993,75 (6) : 1169.
  • 8Gianni, Munzone E, Capri G, et al. Paclitaxel by 3-hour infusion with bolus doxombicin in women with untreated metastaic breast Cancer:high antitumor efficacy and cardiac effects in a dose-finding end sequence-finding study[ J]. J clin oncol 1995,13:2688 -2699.
  • 9Sledge G W Jr Doxorybicin/pacltaxel combination chemotherapy for metastatic breast cancer: the Easten Cooperative Oncology Group experience[ J]. Semin Oncol 1995,22 : 123 - 125.
  • 10Rowinsky EK, Eisentiauer EA, chaudhry V, et al. clinical toxicities, encountered with toxel[ J ]. semin oncol, 1993,20:1.

共引文献47

同被引文献58

引证文献4

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部